MYM Appoints New Director and Insiders Buy Shares

Vancouver, B.C., June 2, 2017 – MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMF), is pleased to announce that Mr. Erick Factor has been appointed to the Company’s Board of Directors and will also serve as Executive Chairman.

Mr. Factor is a well-known expert in the MMJ industry and has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and has provided medical marijuana to thousands of patients over the past two decades. Mr. Factor is also the founder of the “Westcoast Medicann” dispensary, one of just a handful of dispensaries in Vancouver to be licensed under the City of Vancouver’s stringent bylaws. He has extensive experience working with Health Canada, from whom he has obtained MMAR and MMPR licenses for hundreds of patients, and has managed and operated grow facilities to produce for those patients. Mr. Factor has also gained invaluable experience over the past three years in ACMPR licensing regulations and applications.

Insider buying of MYM shares
The following company insiders have purchased shares in the last Private Placement at $0.18:

Chris Jackson – 462,328 shares
Michelle Hackett – 662,328 shares
Mark Forster – 350,000 shares
Jonathan Fiteni – 263,888 shares
Erick Factor – 83,333 shares
Ian Ramage – 40,000 shares
Rob Geitl – 27,778 shares
Judson Culter – 16,667 shares

Total proceeds from insider share purchases was $343,137.96.

MYM also announces that Mr. Chris Jackson has resigned as a director of the Company but will continue to serve as a consultant to the Company’s Chief Executive Officer and to the Board of Directors.

MYM is continuing to negotiate acquisitions of complimentary businesses and assets in the technology, nutraceuticals and CBD sector and is currently in talks with other innovative companies, to ensure a strong presence and growth potential within the industry.
About MYM
MYM Nutraceuticals Inc. (CSE:MYM)(OTC:MYMMF)(FRA:OMY) is a public company trading on the Canadian Stock Exchange whose primary focus is developing high-end organic medicinal cannabis supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market.

“Rob Geitl”
Rob Geitl, CEO
MYM Nutraceuticals Inc.

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.